Hood River Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-318,544
| Closed | -$10.4M | – | 133 |
|
|
2023
Q3 | $10.4M | Buy |
318,544
+5,587
| +2% | +$183K | 0.34% | 83 |
|
|
2023
Q2 | $11M | Sell |
312,957
-765
| -0.2% | -$26.9K | 0.33% | 79 |
|
|
2023
Q1 | $10.2M | Buy |
313,722
+19,855
| +7% | +$648K | 0.33% | 75 |
|
|
2022
Q4 | $16.2M | Buy |
293,867
+1,809
| +0.6% | +$99.7K | 0.59% | 57 |
|
|
2022
Q3 | $12.9M | Buy |
292,058
+6,444
| +2% | +$285K | 0.49% | 64 |
|
|
2022
Q2 | $13.9M | Sell |
285,614
-13,329
| -4% | -$650K | 0.55% | 65 |
|
|
2022
Q1 | $14.5M | Buy |
+298,943
| New | +$14.5M | 0.48% | 69 |
|